Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
(S)-camphor, or L(-)-Camphor, is a stereoisomer of DB01744, a bicyclic monoterpene known to potentiate both heat and cold sensations . (S)-camphor is not the naturally-occurring stereoisomer but displays similar TRPV... DB01744 is isolated from the wood of the camphor laurel tree, Cinnamomum camphora, and had a long history of medicinal use.
- Mechanism
- Curator reviewed · 5 references
TRPV3 cation channels are molecular sensors that play a role in nociception and thermosensation by inducing thermal sensation and heat-induced hyperalgesia. Camphor interacts with TRPV3 channels via pore-region cysteine residues, leading to channel activation and a rise in intracellular calcium levels. Camphor also activates TRPV1 and a TRPV1-like current in dorsal root ganglion (DRG) neurons but inhibits the ankyrin-repeat TRP 1 (TRPA1) channel expressed in most nociceptive DRG neurons, which is responsible for the detection of temperature. The precise role of TRPA1 current inhibition on the analgesic properties of camphor is unclear. Repeated stimulation by camphor leads to sensitization of the TRPV1 and TRPV3 channels, resulting in desensitization, or reduced channel response that likely leads to the analgesic effects of camphor. Camphor also activates cold-sensitive transient receptor potential melastatin 8 (TRPM8) and sensitizes cold-induced calcium transients, which explains the cooling effect of camphor following dermal application. Additionally, camphor was shown to inhibit the TRPM8 receptor response to menthol.
- Primary indication
- Indicated for the temporary symptomatic relief of minor aches and pains of muscles and joints in topical analgesics.Curator reviewed · 2 structured indications
- Formula / weight
- C10H16O · 152.2334 g/mol (avg)
- Also known as
- (1S,4S)-camphor · l-camphor
- Code names
- NSC-26351
Resolves to
DSSYKIVIOFKYAU-OIBJUYFYSA-NSMILESCC1(C)[C@H]2CC[C@]1(C)C(=O)C2What you can answer from here — as of March 06, 2025
Which drugs share a target with (S)-camphor, and which of those have an active Phase 3 trial?